PH+ ALL

Clinical trials for PH+ ALL explained in plain language.

Never miss a new study

Get alerted when new PH+ ALL trials appear

Sign up with your email to follow new studies for PH+ ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to wipe out stubborn leukemia cells before transplant

Disease control Not yet recruiting

This study is testing a combination of two drugs, olverembatinib and inotuzumab ozogamicin, for adults with a specific type of acute leukemia (Ph+ ALL). The goal is to see if this treatment can clear very low levels of remaining cancer cells after initial chemotherapy, which is a…

Matched conditions: PH+ ALL

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

PH+ ALL

Get alerted when new PH+ ALL trials appear

New drug combo aims to wipe out stubborn leukemia cells before transplant